← Eichor
Study identifier: NCT06018272 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Mentalization-based Treatment Versus Bona-fide Treatment for Patients With Borderline Personality Disorder in Germany

Condition: Borderline Personality Disorder  ·  Sponsor: Heidelberg University

PhaseNA
Planned participants304
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

Background: Borderline Personality Disorder (BPD) is a serious mental disorder. Mentalization-based treatment (MBT) is one evidence-based treatment for individuals with BPD. Specifically, MBT has been highlighted for its effectiveness in reduction of suicidal and non-suicidal self-injury (NSSI). Yet, randomized-controlled trials (RCT) on MBT in outpatient settings compared with bona fide treatment (BFT) are still scarce and none has been conducted in Germany. The primary objective of this RCT is to investigate whether outpatient MBT is more effective in the reduction of crisis events (incidences of NSSI and suicide attempts) compared with BFT (namely psychodynamic or cognitive-behavioural psychotherapy) in Germany. Secondary, MBT's efficacy will be investigated with regard to cost-effectiveness, general and interpersonal functioning, BPD and general symptom severity, social adjustment, quality of life, reduction in psychotropic medication and therapy retention. Additionally, moderator as well as common and treatment specific mediator variables will be investigated. Study Design/ Study Population/ Methods: Across 5 study sites in Germany, 304 individuals of all genders from age 18 to 65 with a BPD diagnosis and NSSI or suicide attempts in the past will be asked to participate in the study for two years. In the first year, patients will receive either MBT or BFT (psychodynamic or cognitive behavioural psychotherapy) and will take part in continuous scientific assessments. Scie…

This description comes directly from the study's public registry record.

Talk to the study team

Svenja Taubner, Prof.  ·  +496221564701  ·  svenja.taubner@med.uni-heidelberg.de

Sophie Hauschild, Dr.  ·  sophie.hauschild@med.uni-heidelberg.de

Always discuss trial participation with your own doctor first.

Locations (5)

Psychologische Hochschule BerlinBerlin, GermanyRecruiting
Clinic for Psychosomatic Medicine and Psychotherapy, University Hospital DüsseldorfDüsseldorf, GermanyNot Yet Recruiting
Heidelberg UniversityHeidelberg, GermanyRecruiting
Institute for Psychosocial Medicine, Psychotherapy and PsychooncologyJena, GermanyNot Yet Recruiting
Clinic for Psychosomatic Medicine and Psychotherapy, University Hospital UlmUlm, GermanyNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06018272